Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-015819

Options or other derivatives

  • Director acquired 20,053 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Walker Neal Director 2019-06-04 Grant or award · Employee Stock Option (Right to Buy) +18,951 18,951 D
Walker Neal Director 2019-06-04 Grant or award · Employee Stock Option (Right to Buy) +1,102 1,102 D
Loading xslF345X03/doc4.xml…